Robert Azelby - Net Worth and Insider Trading
Robert Azelby Net Worth
The estimated net worth of Robert Azelby is at least $8 Million dollars as of 2024-05-05. Robert Azelby is the EVP & Chief Commercial Officer of Juno Therapeutics Inc and owns about 89,614 shares of Juno Therapeutics Inc (JUNO) stock worth over $8 Million. Details can be seen in Robert Azelby's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Azelby has not made any transactions after 2018-02-12 and currently still holds the listed stock(s).
Transaction Summary of Robert Azelby
Robert Azelby Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Azelby owns 7 companies in total, including Immunomedics Inc (IMMU) , Clovis Oncology Inc (CLVSQ) , and Alder BioPharmaceuticals Inc (ALDR) among others .
Click here to see the complete history of Robert Azelby’s form 4 insider trades.
Insider Ownership Summary of Robert Azelby
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IMMU | Immunomedics Inc | 2020-06-18 | director |
| CLVSQ | Clovis Oncology Inc | 2018-10-11 | director |
| ALDR | Alder BioPharmaceuticals Inc | 2019-10-22 | director & President and CEO |
 | | 2018-03-09 | director |
| | 2018-03-05 | EVP & Chief Commercial Officer |
| | 2021-08-09 | director & Chief Executive Officer |
| | 2023-04-10 | director |
Robert Azelby Latest Holdings Summary
Robert Azelby currently owns a total of 1 stock. Robert Azelby owns 89,614 shares of Juno Therapeutics Inc (JUNO) as of February 12, 2018, with a value of $8 Million.
Latest Holdings of Robert Azelby
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JUNO | Juno Therapeutics Inc | 2018-02-12 | 89,614 | 86.96 | 7,792,833 |
Holding Weightings of Robert Azelby
Robert Azelby Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Azelby has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the sale of 4,157 shares on February 12, 2018, which brought Robert Azelby around $355,631.
Insider Trading History of Robert Azelby
- 1
Robert Azelby Trading Performance
Robert Azelby Ownership Network
Robert Azelby Owned Company Details
What does Immunomedics Inc do?
Who are the key executives at Immunomedics Inc?
Robert Azelby is the director of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and director & President and CEO Harout Semerjian .
Immunomedics Inc (IMMU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunomedics Inc Insider Transactions
Robert Azelby Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Azelby. You might contact Robert Azelby via mailing address: 307 Westlake Ave. North, Ste 300, Seattle Wa 98109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
